IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FIORENTINI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.120
AS - Asia 3.046
EU - Europa 3.011
SA - Sud America 615
Continente sconosciuto - Info sul continente non disponibili 367
AF - Africa 83
OC - Oceania 6
Totale 14.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.945
CN - Cina 1.039
SG - Singapore 1.037
IT - Italia 645
UA - Ucraina 531
BR - Brasile 504
PL - Polonia 397
DE - Germania 340
HK - Hong Kong 289
FI - Finlandia 251
FR - Francia 244
VN - Vietnam 224
GB - Regno Unito 173
IN - India 116
RU - Federazione Russa 109
TR - Turchia 99
IE - Irlanda 98
CA - Canada 75
BD - Bangladesh 68
AR - Argentina 41
MX - Messico 36
BE - Belgio 33
LT - Lituania 33
ZA - Sudafrica 29
IQ - Iraq 28
SE - Svezia 28
CZ - Repubblica Ceca 25
ID - Indonesia 22
JP - Giappone 21
EC - Ecuador 20
LU - Lussemburgo 20
NL - Olanda 20
ES - Italia 18
IR - Iran 15
PK - Pakistan 15
CR - Costa Rica 13
NG - Nigeria 12
TT - Trinidad e Tobago 11
VE - Venezuela 11
CO - Colombia 10
UZ - Uzbekistan 10
AT - Austria 9
MA - Marocco 9
EG - Egitto 8
JO - Giordania 8
CL - Cile 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
PA - Panama 6
AU - Australia 5
KR - Corea 5
NI - Nicaragua 5
PH - Filippine 5
SA - Arabia Saudita 5
SV - El Salvador 5
TN - Tunisia 5
BO - Bolivia 4
GP - Guadalupe 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
PY - Paraguay 4
AL - Albania 3
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
TJ - Tagikistan 2
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
Totale 13.876
Salva come PNG Salva come JPEG
Città #
Singapore 574
Ashburn 566
Fairfield 556
Woodbridge 487
Jacksonville 393
Warsaw 392
Houston 330
San Jose 316
Hong Kong 287
Chandler 274
Brescia 258
The Dalles 216
Cambridge 212
Seattle 205
Beijing 202
Ann Arbor 196
Wilmington 192
New York 183
Princeton 183
Los Angeles 167
Council Bluffs 166
Helsinki 147
Chicago 140
Nanjing 134
Dublin 98
Lauterbourg 95
Buffalo 87
Dallas 87
Istanbul 77
Columbus 73
Ho Chi Minh City 73
Dearborn 70
Munich 70
Santa Clara 62
Milan 53
Salt Lake City 50
Nanchang 48
Shanghai 48
São Paulo 45
Moscow 44
Hanoi 43
Des Moines 42
Hebei 39
Shenyang 39
Tianjin 38
San Diego 34
San Francisco 34
Elk Grove Village 31
London 31
Jinan 30
Lancaster 29
Brussels 28
Vilnius 28
Changsha 27
Pune 27
Redondo Beach 26
Toronto 26
Orem 25
Tampa 25
Turku 24
Jiaxing 23
Phoenix 23
Brooklyn 22
Denver 22
San Mateo 22
Secaucus 22
Poplar 21
Dong Ket 20
Frankfurt am Main 20
Kunming 19
Tokyo 19
Johannesburg 18
Hangzhou 17
Mexico City 17
Rome 17
San Donà Di Piave 17
Guangzhou 16
Brasília 14
Brno 14
Miami 14
Montreal 14
Rio de Janeiro 14
Verona 14
Ardabil 13
Charlotte 13
Dudelange 13
Leawood 13
Sterling 13
Atlanta 12
Lappeenranta 12
North Bergen 12
Abuja 11
Belo Horizonte 11
Jakarta 11
Manchester 11
Ningbo 11
Chennai 10
Da Nang 10
Augusta 9
Boston 9
Totale 9.095
Salva come PNG Salva come JPEG
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 608
Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus 354
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 303
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 263
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 262
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 243
Immunotherapy failure in adrenocortical cancer: where next? 231
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 219
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 217
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 211
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 203
The D3 dopamine receptor: From structural interactions to function. 197
Palbociclib inhibits proliferation of human adrenocortical tumor cells 196
Kainate Receptor RNA Editing is Markedly Altered by Acute Spinal Cord Injury. 190
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 184
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 184
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 179
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 176
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 172
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 170
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 170
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 167
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 160
Ormoni Anteroipofisari 157
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 156
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 153
The NMDA/D1 receptor complex as a new target in drug development 152
Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons 152
Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons 151
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 149
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 149
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 148
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 143
Dopamine D3 receptor heteromerization: Implications for neuroplasticity and neuroprotection 143
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 141
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 139
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 138
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 138
Nerve growth factor regulates dopamine D2 receptor expression in prolactinoma cell lines via p75NGFR-mediated activation of nuclear factor-kB. 137
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 137
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 137
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 137
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 135
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine 134
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 133
17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons 131
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 130
D1 receptor properties are modulated by its oligomerization with NMDA receptors 128
D1 receptor signalling in basal ganglia function and dysfunctions. 127
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 126
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 125
Eterodimerizzazione tra recettori dopaminergici D1 e D3: implicazioni funzionali e farmacologiche 122
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 120
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 120
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 120
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 119
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 118
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 118
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of the receptor signalling 118
D1 and D3 dopamine receptors form heterooligomers and cointernalization after paired activation of both receptors 117
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 117
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 115
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 115
Phenotype changes of prolactinomas 114
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation 114
Functional implications of dopamine D1 and D3 receptor heterodimerization 112
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 111
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons 109
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway 107
Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications 105
Ormoni anteroipofisari 105
Interactions of Dopamine D1 receptors with D3 receptors and glutamate NMDA receptors 102
Downregulation of dopamine D1/ glutamate NMDA receptor complexes in L-DOPA-induced dyskinesia in the rat 101
Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine 100
Regulation of D1 receptor signalling by direct interaction with the protein tyrosine phosphatase SHP-2 99
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function 97
Frailty and cognitive impairment in elderly patients: miRNAs as new biomarkers (MATCH-In project) 97
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 97
Oligomerization and trafficking of the human dopamine transporter: mutational analysis identifies critical domains important for the functional expression of the transporter. 96
Dendritic remodeling of hippocampal pyramidal neurons, induced by chronic stress and fast-acting antidepressant ketamine, involves miR-9-5p 95
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors 94
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate NMDA receptors 92
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 92
Regulation of G-protein coupled receptor trafficking by receptor-receptor interaction 89
Receptor dimerization and the regulation of neuronal function 88
Farmacologia degli ormoni anteroipofisari 88
Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation 87
Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. 87
Identification and characterization of two Nf-kB binding sites in the human dopamine d2 receptor promotor 85
Meccanismo molecolari e cellulari nel Morbo di Parkinson 84
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 83
Growth factors in pituitary tumors 82
MicroRNAs in frailty associated cognitive impairment MATCH In. 82
Oligomerization of dopamine D1 and glutamate NMDA receptors: a new mechanism regulating striatal function” 79
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of receptor trafficking and function 79
Oligomerization with NMDA receptor as a novel regulatory mechanism of D1 receptor function 78
microRNAs as new biomarkers in frailty associated with cognitive impairment in elderly patients (MATCH-In project) 77
microRNAs as possible biomarkers of frailty and cognitive impairment: the MATCH-In project 77
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 70
Dysregulation of glutamatergic and GABAergic neurons in Treatment-Resistant Depression: Insights from patient-derived neurons 70
Totale 14.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022621 0 0 0 24 6 15 91 42 42 103 70 228
2022/2023771 115 9 18 59 70 225 3 78 122 18 23 31
2023/2024758 56 10 69 73 34 173 27 24 137 27 20 108
2024/20252.143 15 20 9 210 170 182 133 56 169 342 608 229
2025/20263.633 311 463 300 550 363 258 528 178 231 287 102 62
2026/2027973 136 147 277 413 0 0 0 0 0 0 0 0
Totale 14.248